Member Info for MrRipley

Ssssshhhhhhhh. You little boring *****.

Looking at his stress I’m guessing truant has a leveraged short at 110 or so. Him and his other accounts are posting every few minutes. The bizarre thing is they accuse posters of ramping. They then do the total opposite. Nobody is going to read 20 negative posts from the same person and think yeah, they seem balanced. It’s sheer desperation now.

If you want a laugh, have a look at truant and his pals panicking on Twatter. There’s half a dozen, probably the same poster, having a terrible couple of days.

“I am not just focussed on AVA6k, nor therapeutics in general.
#AVCT own an entire biotech vector, affimers, which has a multitude of applications being actively researched.”

What a moron.

Anyone noticed eggy has decided to embrace the fact he’s a twat on Twatter?

“The US trial sites will initially contribute patients to the dose escalation phase, while being uniquely positioned to lead the enrolment of soft tissue sarcoma patients in the phase 1b dose expansion stage of the AVA6000 study”

This is genuinely great news in terms of time lines. I’d say H1 is now much more likely with these 2 sites onboard.

I think we may get a combination of panicked shorters trying to add like truant and friends being outdone by people adding to their ISAs today. Hopefully even more news to come pre AACR. It’s good to see more sites come online which hopefully means less delays going forward.

Maybe he hates PIs that much he decided to release news on the last day of the tax year and the first of the new one just to screw a few over doing bed and ISAs hahaha.

So the end of 2024 for P1b to complete. That’s based on their own timeline of around 15 months to complete, and allowing for no slippage.

So our best hope for funding is a license for 3996 really and about now is the time it’s most likely to happen (as per the article I posted) so AACR data is very important. Beyond that AS needs to give us a road map, if he isn’t farrrrrrr to busy to do another 14 minute interview. But that tan….. really looks top draw.

Right. That’s enough if this ****e. Toodle pip.

Writes out response…. Then deletes. Annotate to, shut up investors, and isn’t his tan looking great.

The previous just wasn’t worth the agro. Noted though, don’t ask questions, they’re busy. Right’o.

Next. 2 months to set up P1b (unless I mis heard) means he plans on getting each of these cohorts done within 12 weeks to get us to his H1 target, and then it’ll be July and august to set up P1b, then September to begin P1b…. Correct? Then 12-18 months for P1b, or am I miles off there?

Being airborne doesn’t mean it’s in every square inch of air everywhere you know? The idea was to wear it in public places. Your post makes no sense. Did you think stood in a field in the middle of nowhere would still pose a risk of infection if it were a windy day? Hahaha.

Over the standard increase Tim.

That’s quite a cautious approach, an extra 10mg. Can we assume 300mg will be MTD?

Correct. It’s David. But we can call him Alastair.

To see Avacta announce the new secretary, see Tom the Bomb Twitter for details. Big news. Responsible for making the orange squash and pressing the open door button! And you know what that means! That’s right, people want to get in!

Delusional is not admitting you sold at a quid, missed the rise to 185 and instead lost 30% in Harl. It’s all facts you absolute fantasist. Gambler.

https://www.begambleaware.org/self-assessment-tool-entry?gclid=Cj0KCQjwz6ShBhCMARIsAH9A0qUNhsRtV0GVKC0aDNeQTVBO02LYwn3SUGdxO2J22ICa4_Cwo29zLCYaAnTrEALw_wcB

You didn’t hold til 185. You did sell at a quid. You are 30% down at Harl. All facts.

“I could not see AVCt going anywhere anytime soon, it was based on belief there was a delay coming and the possibility of a further cohort. The SP now is about 10% higher than it was then.”

Just totally denying the 85% rise in the middle there. It went up 85%. That’s hardly going nowhere. Meanwhile Harl is down 30%. So if charting was so great it would have been an 85% rise sold into and Harl bought 30% lower. Or to put it in monetary terms 10k would have been £18,500 and at one point a 40% discount in Harl would have been possible. Instead that 10k rolled into Harl would be worth 7k now, or a difference of £11,500 and a loss of 3K. That is dreadful trading.

Good luck to everyone fully understanding results if Bein is gone. Biggest loss to the board.

Yes Kevin. Lots of posters expecting the next cohort to actually start so that the already late completion of P1a, hits it’s new H1 deadline. It won’t. It’ll be a year late and that isn’t for free. These expectations are set by Avacta, not us.